Drug delivery Systems (DDSs) are polymeric or lipid carrier systems that transport medications to their targets or receptor sites in a way that ensures their maximum Therapeutic Activity, prevents drug degradation or inactivation while travelling to the target site (s), and shields the body from negative effects caused by inadvertent administration. It can be characterised as a formulation or a tool that permits the entrance of a medicinal material into the body and increases its efficacy and safety by regulating the rate, timing, and site of drug release.
Release of the drug(s) with the highest levels of safety, effectiveness, and dependability is the aim of an ideal DDS. Combining a number of cutting-edge methods, the Novel Drug Delivery System (NDDS), also known as controlled DDS In order to improve medication potency, control drug release, increase safety, and specifically target a drug to a targeted region, novel drug delivery systems (NDDS), also known as Controlled DDS, combine cutting-edge technology and innovative dosage forms. The definition of "controlled release" extends beyond actions that solely include continuous release. In other words, the release kinetics of controlled release must be able to be predicted and replicated.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada